TLR4 and candidiasis: Therefore, these compounds could be considered for use as a potential treatment for candidiasis in humans via modulating proteins such as, STAT3, IL-2, PTPRC, STAT1, CASP1, ALB, TP53, TLR4, TNF and PPARG.